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See related research by Qin et al., http://www.arthritis-research.com/content/17/1/86
and related letter by Liu and Barnabe, http://dx.doi.org/10.1186/s13075-015-0744-9We thank Liu and Barnabe for their valuable comments
[1] on our article [2]. We think the majority of the re-
marks they made were reasonable and helpful for a deep
understanding of the association of body mass index
(BMI) and rheumatoid arthritis (RA) risk. Indeed, the
three papers they mentioned discussed the role of obes-
ity in RA development. Actually, we also identified these
three papers when searching for potential papers; however,
our paper is not a descriptive review, but a quantitative
systematic review. We had strict inclusion criteria as
described in our paper, with included studies having to
fulfill the following criteria: (1) the study had a case–
control or cohort design; (b) the study included risk esti-
mates with the corresponding 95 % confidence intervals,
or sufficient data for extraction or assessment; and (c)
obesity, being overweight, and BMI were the exposures of
interest [2]. Hemminki et al. [3] estimated standardized
incidence ratio for RA in obese individuals compared with
those who had not been hospitalized for obesity. This
study was a cohort design and obesity was the exposure of
interest, but we could not extract and calculate the risk es-
timates of RA development in the obese population. We
therefore excluded this paper. Vessey et al. [4] reported
no significant association between RA development and
either weight or height. The exposure of interest was
not obesity, being overweight, or BMI. Besides, no risk
estimates could be obtained from this paper. For similar
reasons we did not include Bartfai et al.'s paper [5]. Thus,
we did not include these three papers due to insufficient
data for calculation of pooled risk estimates.* Correspondence: yangzaixingdiyi@163.com; 13901628473@163.com
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the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeAlthough several studies gave negative results, the com-
bined results obtained from our quantitative meta-analysis
have demonstrated that an increase in BMI could contrib-
ute to a higher risk for RA development. However, the real
relationship between obesity, BMI and RA risk should be
conducted in a large RA cohort with adjustment for more
confounding factors.
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